Zhengxing Li

University of California San Diego

Papers

6

Total Citations

822

H-Index

6

About

Zhengxing Li is a pioneering researcher at the forefront of biohybrid microrobotics, with a particular focus on engineering living microorganisms into functional robotic systems for biomedical and environmental applications. His work elegantly bridges biological science and robotics engineering, transforming natural cells — including platelets and microalgae — into sophisticated, autonomously navigating delivery vehicles. Li's most celebrated contribution, his 2020 paper on enzyme-powered Janus platelet cell robots (413 citations), demonstrated that natural cells could be engineered into biocompatible micromotors capable of active, targeted drug delivery — a landmark advance over conventional passive drug delivery systems. Building on this foundation, his laboratory has developed microalgae-based biohybrid robots capable of operating in extreme physiological environments, including the acidic stomach, and even tackling environmental challenges such as capturing SARS-CoV-2 from wastewater using ACE2-modified algal robots (94 citations). His more recent work addresses formidable clinical challenges, including lung metastasis and inflammatory bowel disease, demonstrating that biohybrid microrobots can meaningfully improve therapeutic outcomes where conventional treatments fall short. With over 800 cumulative citations across six landmark papers, Li's research is rapidly shaping the future of precision medicine and intelligent biomedical robotics.

Research Focus

Key Achievements

6
H-Index
6
Papers
822
Total Citations
137
Avg Citations/Paper
🏆 Most Cited Paper
Enzyme-powered Janus platelet cell robots for active and targeted drug delivery
413 citations · 2020
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: University of California San Diego

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago